NP-12 NP 031112 Tideglusib raw Powder CAS 865854-05-3 Tideglusib
COA TDS 12 Inquiries
865854-05-3
Pharmaceutical Grade
99%
shenzhen
HS
25kg drum
Yes
2026-10-21
Ivermectin,Active pharmaceutical ingredients,Cosmetics material,Chemical intermediate,Nootropic,Food additive
-
Product Details
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceTideglusib is an irreversible GSK-3 inhibitor with IC50s of 5 nM and 60 nM for GSK-3βWT (1 h preincubation) and GSK-3βC199A (1 h preincubation), respectively.
Tideglusib is a member of the class of thiadiazolidines that is 1,2,4-thiadiazolidine-3,5-dione which is substituted by a naphthalen-1-yl group at position 2 and by a benzyl group at position 4. It is a non-ATP competitive inhibitor of glycogen synthase kinase 3beta (GSK3beta) and has neuroprotective effects. Currently under clinical investigation for the treatment of Alzheimer's disease and progressive supranuclear palsy. It has a role as an EC 2.7.11.26 (tau-protein kinase) inhibitor, a neuroprotective agent, an anti-inflammatory agent and an apoptosis inducer. It is a member of naphthalenes, a member of benzenes and a thiadiazolidine.|Tideglusib is under the investigation for the development of treatments for Alzheimer's disease and for progressive supranuclear palsy. It is reported to be a potent anti-inflammatory and neuroprotective that is a non-ATP competitive inhibitor of glycogen synthase kinase 3 (GSK-3). Tideglusib is being developed by the Spanish pharmaceutic company Zeltia group and its current status is withdrawn for the treatment of Alzheimer's disease as of 2012.CertificatesBasic Info-
Product Name:
Tideglusib
Other Name:1,2,4-Thiadiazolidine-3,5-dione,2-(1-naphthalenyl)-4-(phenylmethyl)-;2-(1-Naphthalenyl)-4-(phenylmethyl)-1,2,4-thiadiazolidine-3,5-dione;4-Benzyl-2-(naphthalen-1-yl)-[1,2,4]thiadiazolidine-3,5-dione;Tideglusib;NP 12;NP 031112;945421-01-2;1073650-08-4
CAS No.:865854-05-3
Molecular Formula:C19H14N2O2S
InChIKeys:InChIKey=PMJIHLSCWIDGMD-UHFFFAOYSA-N
Molecular Weight:334.39166
Exact Mass:334.39
UNII:Q747Y6TT42
DSSTox ID:DTXSID90235682
Categories:
Characteristics-
PSA:
65.9
XLogP3:4.3
Appearance:white to beige
Density:1.4±0.1 g/cm3
Melting Point:148-150ºC
Boiling Point:511.3ºC at 760 mmHg
Flash Point:263.0±28.2 °C
Refractive Index:1.735
Water Solubility:Sparingly soluble with water.DMSO: >15mg/mL
Storage Conditions:2-8°C
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Ivermectin,Active pharmaceutical ingredients,Cosmetics material,Chemical intermediate,Nootropic,Food additive
-
Location:
6 floor Baoyilongji Building B Weiyang Area, Fengcheng 8 Road, Xi'an city, Shaanxi, 710000, China
-
Payment Terms:
L/C,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
7 days
-
Total Annual Revenue:
$5 million-$10 million
-
Total Employees:
51-100
-
Year of Establishment:
2017
Company Certificates-
ISO
-
ISO
-
-
Inquiry History12 Inquiries
Country Product Purchase Quantity Date Posted
United States
High Purity Tideglusib 99% Powder CAS 865854-05-3 EGC-Tideglusib Powder
1 MT Oct 31, 2023
United States
Tideglusib
25 G Jun 13, 2026
United States
Tideglusib
100 G Sep 13, 2026
Russia
Tideglusib
0.1 KG Jan 26, 2025
United States
Tideglusib
100 MG Apr 17, 2024
Slovenia
Tideglusib
1 KG Mar 20, 2024
United States
tideglusib
1 G Oct 11, 2026
United Kingdom
Tideglusib
25 G Jun 8, 2026
United States
Tideglusib
10 G Apr 25, 2024
United States
Tideglusib
100 MG Apr 16, 2024
United States
Tideglusib
100 G Sep 17, 2026
Spain
Tideglusib
1 KG Mar 29, 2025 Post an enquiry for this product
More from this Seller
-
-
-
Citrus Aurantium Extract HPLC Synephrine HCl Powder CAS94-07-5 Synephrine
Pharmaceutical Grade / 99%
-
-
-
-
CAS 2415797-61-2 API Orforglipron hemicalcium hydrate LY3502970 HEMICALCIUM
Pharmaceutical Grade / 99%
-
-
-
-
Dydrogesterone 98% white powder CAS 152-62-5 Dydrogesterone
Pharmaceutical Grade / 99%
-
-
-
-
NSI-189 Nootropic Raw Powder CAS 1270138-40-3 Nsi-189 Phosphate
Pharmaceutical Grade / 99%
-


